OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Transcriptomics
(1)
Organisms
Homo sapiens
(1)
Repository
biostudies-arrayexpress
(1)
Publication Date
2013
(1)
Study type
Transcription profiling by array
(1)
Release Date
2013
(3)
2017
(2)
2011
(2)
2018
(1)
2016
(1)
2015
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Temperature-induced melting of double-stranded DNA in the absence and presence of covalently bonded antitumour drugs: insight from molecular dynamics simulations.
Not available
S-EPMC3185422
|
biostudies-literature
Cite
c-Jun N-terminal kinase phosphorylation is a biomarker of plitidepsin activity.
Not available
S-EPMC3707168
|
biostudies-literature
Cite
Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy.
Not available
S-EPMC6209089
|
biostudies-literature
Cite
Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway.
Not available
S-EPMC3799600
|
biostudies-literature
Cite
Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair.
Not available
S-EPMC5041952
|
biostudies-literature
Cite
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models.
Not available
S-EPMC5572168
|
biostudies-literature
Cite
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.
Not available
S-EPMC4662461
|
biostudies-literature
Cite
Irvalec inserts into the plasma membrane causing rapid loss of integrity and necrotic cell death in tumor cells.
Not available
S-EPMC3083409
|
biostudies-literature
Cite
PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity.
Not available
S-EPMC2998690
|
biostudies-literature
Cite
Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer.
Not available
S-EPMC5452066
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets